Skip to content

Transvaginal Electromechanical Fragmentation and Removal of Large Uterus in a Sealed Bag: The First Group of Clinical Studies Balancing Scar - Free and Anti - Dissemination

Transvaginal Electromechanical Fragmentation and Removal of Large Uterus in a Sealed Bag: The First Group of Clinical Studies Balancing Scar - Free and Anti - Dissemination

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07486622
Enrollment
25
Registered
2026-03-20
Start date
2025-03-01
Completion date
2026-03-10
Last updated
2026-03-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adenomyosis, Enlarged Uterus, Uterine Fibroids

Keywords

Uterine Fibroids, Adenomyosis, Enlarged Uterus

Brief summary

This study evaluates the feasibility, safety, and efficiency of transvaginal in-bag electromechanical morcellation for specimen extraction in patients undergoing total laparoscopic hysterectomy for large uteri.

Detailed description

This single-center prospective study investigates a novel transvaginal specimen extraction technique using a sealed containment bag combined with electromechanical morcellation. The procedure aims to improve specimen extraction efficiency while preventing tissue dissemination during laparoscopic hysterectomy for uteri larger than 12-week gestational size.

Interventions

None listed

Sponsors

Chang Zhou
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
38 Years to 52 Years
Healthy volunteers
No

Inclusion criteria

Female patients aged 38 to 52 years Planned to undergo total laparoscopic hysterectomy Uterine size greater than 12 weeks gestational size based on preoperative imaging Eligible for transvaginal specimen extraction Able and willing to provide written informed consent

Exclusion criteria

Advanced gynecologic malignancy Severe pelvic obliteration preventing transvaginal access Contraindication to laparoscopic surgery Pregnancy Inability or unwillingness to provide informed consent

Design outcomes

Primary

MeasureTime frameDescription
Containment bag integrityImmediately after specimen extractionIntegrity of the specimen containment bag assessed using methylene blue leakage testing following specimen extraction

Secondary

MeasureTime frameDescription
Specimen extraction timePeriprocedurallyDuration required to complete transvaginal in-bag electromechanical morcellation and removal of the uterine specimen, measured in minutes.
Total operative timeImmediately after surgeryTotal duration of surgery measured from skin incision to completion of wound closure.
Estimated intraoperative blood lossDuring surgeryEstimated blood loss recorded during the surgical procedure.
Postoperative complicationsUp to 30 days postoperativelyIncidence of postoperative complications including infection, fever, or organ injury.
Length of postoperative hospital stayUp to 7 days postoperativelyNumber of days from surgery until hospital discharge.

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 21, 2026